Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: Possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer

British Journal of Cancer

Volumn 69, Issue 1, 1994, Pages 72-76

  Yamashita, J I ^a   Sato, H ^b   Ikei, S ^a   Omachi, H ^a   Yamashita, S I ^a   Saishoji, T ^a   Nomura, K ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LEUKOCYTE ELASTASE;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CULTURE MEDIUM; ENZYME IMMUNOASSAY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; SURVIVAL TIME; TUMOR CELL LINE;

BREAST NEOPLASMS; FEMALE; HUMAN; LEUKOCYTE ELASTASE; MIDDLE AGE; NEUTROPHILS; PANCREATIC ELASTASE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028011997     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.11     Document Type: Article

References (40)

1. BALO, J. & BANGA, I. (1949). Elastase and elastase inhibitor. Nature, 164, 491–493.
2. BANDA, M.J. & WERB, Z. (1981). Mouse macrophage elastase. Biochem J., 193, 589–605.
3. BAUGH, R.J. & TRAVIS, J. (1976). Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry, 15, 836–841.
4. BLOOM, H.J.G. & RICHARDSON, W.W. (1957). Histologic grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br. J. Cancer, 11, 359–377.
5. CAJOT, J.F., KRUITHOF, E.K.O., SCHLEUNING, W.D., SORDAT, B. & BACHAMANN, F. (1986). Plasminogen activators, plasminogen activator inhibitors and procoagulant analysed in twenty human tumor cell lines. Int. J. Cancer, 38, 719–727.
6. COX, D.R. (1972). Regression models and life tables. J. R. Stat. Soc. (B), 34, 187–202.
7. DUFFY, M.J. (1987). Do proteases play a role in cancer invasion and metastasis? Eur. J. Cancer Clin. Oncol., 23, 583–589.
8. DUFFY, M.J., O’GRADY, P., DEVANEY, D., O’SIORAIN, L., FENNELLY, J.J. & LIJNEN, H.R. (1988). Urokinase-plasminogen activator, a marker for aggressive breast carcinomas – preliminary report. Cancer, 62, 531–533.
9. GRANT, A.J., LERRO, K.A. & WU, C.-W. (1990). Cell associated elastase activities of rat mammary tumour cells. Biochem. Int., 22, 1077–1084.
10. HECK, L.W., CATERSON, B., CHRISTNER, J.E. & BAEKER, J R. (1982). The interaction of human neutrophil elastase and cathepsin G with rat chondrosarcoma proteoglycan aggregate. Fed. Proc., 41, 506.
11. HORNEBECK, W., DEROUETTE, J.C., BRECHEMIER, D., ADNET, J.J. & ROBERT, L. (1977). Elastogenesis and elastinolytic activity in human breast cancer. Biomedicine, 26 48–52.
12. IKEI, S., OGAWA, M., SAMEJIMA, H., ARAKAWA, H., SUGITA, H., YAMASHITA, J., SATO, H., TATEMATSU, A. & SATO, I. (1992). Evaluation of newly developed enzyme-immunoassay kit for neutrophil elastase. Jpn. J. Clin. Exp. Med., 69, 2944–2950.
13. INADA K., YAMASHITA, J., MATSUO, S., NAKASHIMA, Y., YAMASHITA, S. & OGAWA, M. (1992). Hormone control of total plasminogen activator activity is specific to malignant DM BA-induced rat mammary tumours. Br. J. Cancer, 65, 578–582.
14. JANICKE, F., SCHMITT, M., HAFTER, R., HOLLRIEDER, A., BABIC, R., ULM, K., GOSSNER, W. & GRAEFF, H. (1990). Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis, 4, 238–240.
15. JANOFF, A. & SCHERE, J. (1968). Elastolytic activity in granules of human polymorphonuclear leukocytes. J. Exp. Med., 128, 1137–1156.
16. JAPANESE BREAST CANCER SOCIETY (1989). Histological classification of breast tumors. In General Rule for Clinical and Pathological Record of Mammary Cancer, 10th edn, pp. 21-57. Kanehara: Tokyo.
17. KAO, R.T., WONG, M. & STERN, R. (1982). Elastin degradation by proteases from cultured human breast cancer cells. Biochem. Biophys. Res. Commun., 105, 383–389.
18. KAPLAN, E.L. & MEIER, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457–481.
19. MCDONALD, J.A. & KELLEY, D.G. (1980). Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J. Biol. Chem., 255, 8848–8858.
20. MACHOVICH, R. & OWEN, W.G. (1989). An elastase-dependent pathway of plasminogen activation. Biochemistry, 28, 4517–4522.
21. MAINARDI, C., DIXIT, S. & KANG, A. (1980). Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granule. J. Biol. Chem., 255, 5435–5441.
22. MANTEL, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163–170.
23. MIGNATTI, P., ROBBINS, E. & RIFKIN, D.B. (1986). Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487–498.
24. MIRA-Y-LOPEZ, R., OSBORNE, M.P., DEPALO, A.J. & OSSOWSKI, L. (1991). Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy. Int. J. Cancer, 47, 827–832.
25. NEUMANN, S., HENNRICH, H., GUNZER, G. & LANG, H. (1984). Enzyme-linked immunoassay for human granulocyte elastase in complex with alpha,-proteinase inhibitor. In Proteases: Potential Role in Health and Diseases, Horl, W. & Heidland, A. (eds) pp. 379-390. Plenum Press: New York.
26. PARANJPE, M., ENGEL, L., YOUNG, N. & LIOTTA, L.A. (1980). Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci., 26, 1223–1231.
27. PERSKY, B., OSTROWSKI, L.E., PAGAST, P., AHSAN, A. & SCHULTZ, R.M. (1986). Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion. Cancer Res., 46, 4129–4134.
28. RECKLIES, A.D., TILTMAN, K.J., STOKER, A.M. & POOLE, A.R. (1980). Secretion of proteinases from malignant and non-malignant human breast tissue. Cancer Res., 40, 550–556.
29. REICH, R., THOMPSON, E.W., IWAMOTO, Y., MARTIN, G.R., DEASON, J.R., FULLER, G.C. & MISKIN, R. (1988). Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res., 48, 3307–3312.
30. SPYRATOS, F., MAUDELONDE, T., BROUILLET, J.P., BRUNET, M., DEFRENNE, A. & ROCHEFORT, H. (1989). Cathepsin D: an important marker predicting metastasis in primary breast cancer. Lancet, ii, 1115–1118.
31. STUMP, D.C., LIJNEN, H.R. & COLLEN, D. (1986). Purification and characterization of single-chain urokinase-type plasminogen activator from human-cell culture. J. Biol. Chem., 261, 1274–1278.
32. TANDON, A.K., CLARK, G.M., CHAMNESS, G.C., CHIRGWIN, J.M. & MCGUIRE, W.L. (1990). Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 322, 297–302.
33. TURPEENNIEMI-HUJANEN, T., THORGEIRSSON, U.P., HART, I.R., GRANT, S.S. & LIOTTA, L.A. (1985). Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Natl Cancer Inst., 75, 99–103.
34. WORLD HEALTH ORGANIZATION (1981). Histological typing of breast tumours. In International Histological Classification of Tumours, No. 2. Geneva: World Health Organization.
35. YAMASHITA, J., HORIUCHI, S., KIMURA, M., NISHIMURA, R. & AKAGI, M. (1986). Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells. Jpn. J. Cancer Res., 77, 177–181.
36. YAMASHITA, J., HORIUCHI, S., SHIGAKI, N., FUJINO, N. & AKAGI, M. (1984). Estrogen-dependent plasminogen activator in 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumors in vivo and in vitro. Jpn. J. Cancer Res., 75, 681–689.
37. YAMASHITA, J., INADA K., YAMASHITA, S., MATSUO, S., NAKASHIMA, Y. & OGAWA, M. (1992). Demonstration of a possible link between high grade malignancy in dimethyl-benz(a)anthracene-induced rat mammary carcinoma and increased urokinase plasminogen activator content. Int. J. Clin. Lab. Res., 22, 165–168.
38. YAMASHITA, J., OGAWA, M., INADA K., YAMASHITA, S., NAKASHIMA, Y., SAISHOJI, T. & NOMURA, K. (1993a). Breast cancer prognosis is poor when total plasminogen activator activity is low. Br. J. Cancer, 67, 374–378.
39. YAMASHITA, J., OGAWA, M., YAMASHITA, S., NAKASHIMA, Y., SAISHOJI, T., NOMURA, K., INADA K. & KAWANO, I. (1993b). Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer. Br. J. Cancer, 68, (in press).
40. ZEYDEL, M., NAKAGAWA, S., BIEMPICA, L. & TAKAHASHI, S. (1986). Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. Cancer Res., 46, 6438–6445.